CompletedNot Applicable

Survival and Reproductive Outcomes of Malignant Ovarian Germ Cell Tumors

Egypt27 participantsStarted 2023-05-01

Plain-language summary

Malignant ovarian germ cell tumor patients conducted fertility-sparing surgery and adjuvant chemotherapy in Kasr El-Aini Hospital - Faculty of Medicine - Cairo University from January 2012 to December 2016 will be retrospectively investigated.

Who can participate

Age range18 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age : younger than 35 years old at first treatment. * Fertility-sparing surgery and adjuvant chemotherapy. * Pathological diagnosis of malignant ovarian germ cell tumor. Exclusion Criteria: * Patients with benign ovarian germ cell tumors e.g. mature teratoma. * Concurrent malignancy. * Severe comorbidities that may affect ovarian reproductive function.

What they're measuring

reproductive outcomes

Timeframe: 5 years

Trial details

NCT IDNCT05905289

SponsorCairo University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-11

View on ClinicalTrials.gov More Fertility Issues trials